Clinical Trials Browser

Phase 2/3 × palbociclib × Clear all

NCT04191499 2026-03-17

INAVO120

Phase 2/3 Active not recruiting

325 enrolled 14 charts 1 FDA

Breast Neoplasms

NCT02692755 2021-09-28

PALINA

Phase 2/3 Completed

35 enrolled 12 charts

Hormone Receptor Positive HER-2 Negative Breast Cancer